PTPRC and graft versus host disease: When engrafted with human PBMCs, NOG-IL-15 mice showed approximately 11.3 +/− 1.5% NK cells of total human CD45+ cells, as well as acute GVHD and increased mortality compared to humanized NOG mice [70].